Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Enid and George - Life with dementia

phosphodiester1 - brain health1 - cjd2 - parkinson's dementia1 - peanut butter1 - blood pressure6 - apraxia3 - loss of memory3 - chuanhai cao1 - neurodegenerative disorder4 - problems with speech1 - fish oil supplements1 - alzheimer’s patients1 - cause tuberculosis1 - apolipoprotein e41 - delirious episode1 - vad2 - declines in memory1 - national alzheimer's project act1 - amylin deposition1 - lewis and short1 - cognition function1 - single-infarct dementia1 - delusional misidentification1 - amyloid-β421 - parkinson's risk2 - dantrolene1 - fibrous tangles1 - hiv patients1 - anticholinergics1 -